ALIGN TECHNOLOGY INC (ALGN)
About ALIGN TECHNOLOGY INC
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $4.0B
- Net income
- $410.4M
- Total assets
- $6.2B
- Market cap
- $12.0B
- Gross margin
- 67.2%
- Operating margin
- 13.5%
- Net margin
- 10.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.0B
- Cost of revenue
- $1.3B
- Gross profit
- $2.7B
- Operating expenses
- $2.2B
- Operating income
- $545.8M
- Income tax
- $174.9M
- Net income
- $410.4M
- EPS (basic)
- $5.66
- EPS (diluted)
- $5.65
Balance sheet
- Total assets
- $6.2B
- Current assets
- $2.6B
- Total liabilities
- $2.2B
- Current liabilities
- $1.9B
- Shareholders’ equity
- $4.0B
Cash flow
- Operating cash flow
- $593.2M
- Investing cash flow
- -$112.4M
- Financing cash flow
- -$464.6M
- Net cash flow
- $51.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $12.0B
- P/E ratio
- 29.6
- EPS (diluted)
- $5.65
- Shares outstanding
- 71.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 26, 2001
Align Technology Inc (ALGN) Stock Price
- Profitable — net income of $410.4M in FY2025.
- Revenue grew 63% from FY2020 to FY2025.
- Gross margin of 67.2%, net margin 10.2%.
- Trading 19% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 29.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ALIGN TECHNOLOGY INC.
Write a review
News about ALIGN TECHNOLOGY INC
News & sentiment via Polygon.io
Align Technology Inc: frequently asked questions
Is Align Technology Inc an American company?
Yes — Align Technology Inc is an American company headquartered in Tempe, Arizona. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Align Technology Inc headquartered?
Align Technology Inc is headquartered in Tempe, Arizona, United States.
Is Align Technology Inc publicly traded?
Yes — Align Technology Inc is a publicly traded company. Its stock trades under the ticker symbol ALGN on the NASDAQ.
What does Align Technology Inc do?
Align Technology Inc is an American Medical Devices company in the Health & Beauty sector.
